Related Experiment Video
Updated: Sep 6, 2025

11:09
Revealing the Cytoskeletal Organization of Invasive Cancer Cells in 3D
Published on: October 26, 2013
15.9K
Structural variations in cancer and the 3D genome
Frank Dubois1,2,3,4, Nikos Sidiropoulos5,6, Joachim Weischenfeldt7,8,9
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nature Reviews. Cancer
|June 28, 2022
Summary
Structural variations (SVs) impact cancer genomes more than other genetic changes. Their occurrence and effects are highly specific to cancer types, influenced by 3D genome folding.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Structural variations (SVs) are significant genomic alterations in cancer but are challenging to detect and interpret.
- Understanding SVs is crucial for clinical cancer sequencing and interpreting their biological and clinical relevance.
- Recent analyses highlight cancer-type-specific features influencing SV generation and impact.
Purpose of the Study:
- To discuss how 3D genome folding influences SV rates across different cancer types.
- To explore the impact of SVs on cancer cell fitness.
- To provide a perspective on the specificity of SVs in cancer compared to other genetic alterations.
Main Methods:
- Analysis of large whole-genome sequencing datasets.
- Comparative analysis of SV rates across different cancer types.
- Investigating the relationship between 3D genome structure and SVs.
- Evaluating the influence of SVs on cancer cell selective fitness.
Main Results:
- SV rates and their generation mechanisms show significant specificity across different cancer types.
- The three-dimensional (3D) folding of the genome influences observed SV rates.
- SVs play a distinct role in the selective fitness of cancer cells, varying by cancer type.
- SVs affect a larger portion of the cancer genome than other somatic genetic alterations.
Conclusions:
- The 3D genome architecture is a key determinant of structural variation patterns in cancer.
- Structural variations are cancer-type-specific drivers of genomic alteration and evolution.
- Interpreting SVs in the context of 3D genome organization is essential for understanding cancer biology and developing clinical strategies.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
What is Cancer?
11.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
11.1K
Cancer
49.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

